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SUMMARY 
Background: Systemic Lupus Erythematosus (SLE) is said to be rare in Sub-Saharan Africa and even rarer in males 
worldwide. SLE is mostly considered a disease of women, though men may also be affected, and this may lead to a 
delay in diagnosis in men. The result is a greater burden of inflammation and subsequent organ damage over time.  
Method: Data from the medical records of 13 male patients diagnosed with SLE at the Rheumatology Clinic of Korle-
Bu Teaching Hospital between January 2014 and January 2017 was retrospectively analyzed.  
Results: A total of 13 male patients out of a total of 134 SLE patients were included in our analysis. The mean age 
was 30.62 ± SD 8.47 years (range of 17 to 46 years). All of them (100%) presented with constitutional features. The 
most common ACR criteria observed was 61.5 % rash, 54.5 % oral ulcers, 92.3% arthritis, 61.5 % serositis and 38.5% 
renal involvement, 46.2 % CNS involvement. Looking at their serological profile, 91.7 % had a positive antinuclear 
antibody (ANA). 33.3 % had positive anti-dsDNA and 58.3 % extractable nuclear antigens. The mean duration from 
onset of symptoms to diagnosis was 21.31 months. Five patients were diagnosed with lupus nephritis, all at the time 
of diagnosis. There were no mortalities. 
Conclusion: Male SLE patients in Ghana are comparable to other populations, with arthritis and constitutional 
features being predominant early features and lupus nephritis being the main early indicator of organ damage. This 
should warrant aggressive management in male patients.  
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INTRODUCTION 
SLE is a clinically heterogeneous autoimmune disease of 
unknown etiology. It is characterized serologically by 
autoantibodies targeting self-proteins.  Organs and cells 
of affected individuals undergo damage mediated by 
tissue-binding autoantibodies and immune complexes.  
 
The onset and severity of symptoms appears to be 
influenced by environmental factors (such as sunlight, 
drugs and chemicals, and infectious agents), coupled 
with a strong underlying genetic susceptibility to this 
complex disease.1 SLE is said to be rare in Sub-Saharan 
Africa and even rarer in males worldwide.  
 
The incidence of SLE is markedly increased in females 
of child-bearing age with a male to female ratio of  8-
15:1, suggesting a hormonal influences in the cause.2 
Further evidence for hormonal influence comes from the 
fact that the ratio of female to male cases is much lower 
in prepubertal children and after menopause, although a 
female predominance remains.3 Reported pre-pubertal 
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Factors accounting for female predominance 
Potential causes of the female predilection for SLE 
included the effects of estrogen and its hydroxylation, 
decreased androgen levels, hyperprolactinemia and 
differences in gonadotropin-releasing hormone (GnRH) 
signaling.5  
 
Sex hormones have been shown to interact with the 
immune system, including the B cell and T cell 
compartment, dendritic cells and cytokine networks. It is 
thought that female sex hormones cause enhanced 
autoimmune reactivity and contribute to the 
immunological disconcertion that results in SLE.6 The 
female hormonal influences include supporting the 
survival of autoreactive B cells and modifying their 
maturation toward a marginal zone phenotype, while 
male hormones produce the opposite effects. 7 
 
A publication by Cattalani et al., outlining differences 
between sexes in paediatric patients revealed sex 
dimorphism to be less evident in childhood autoimmune 
disease possibly on account of minor differences in 
hormonal environment between males and females.8 
Krassaelt and Baerwald in a review highlights that female 
sex hormones like estradiol not only increase risk of SLE 
but also influence the course of the disease.9 The use of 
exogenous hormones has been associated with lupus 
onset and flares, suggesting a role for hormonal factors in 
the pathogenesis of the disease.10 
 
 Interestingly, in men, SLE is suggested to be more 
common in those with Klinefelter Syndrome (ie, 
genotype XXY), further supporting a hormonal 
hypothesis.11 In fact, a study by Dillon et al found that 
men with SLE and Klinefelter syndrome had a more 
severe course of SLE than women, but they had a  less 
severe course than other men.12 A study done on the 
profile of sex hormones in male patients with systemic 
lupus erythematosus showed no significant differences in 
serum Testosterone (T), Estrogen (E2), Prolactin(PRL) 
levels and E2/T ratio between male SLE patients and 
controls. However, patients with SLE had significantly 
higher levels of gonadotrophins.13 
 
Differences in Clinical Presentation of Male SLE 
The greater awareness of SLE as a potential diagnosis in 
females, may lead to a greater delay in diagnosis in men 
presenting with similar symptoms. The consequence 
would be a greater burden of inflammation and 
subsequent damage over time. Alternatively, if men 
displayed an atypical phenotype at presentation, a delay 
in diagnosis, and thus treatment, might result .14 In a 
study done by Tan et al,15 men were more likely than 
women to have disability.  
 
Men were more likely to be diagnosed at an older age and 
to have a lower education level. Men were more likely 
than women to have experienced end organ damage 
including neuropsychiatric, renal, cardiovascular, 
peripheral vascular disease, and myocardial infarction, 
and to have died.  
 
Earlier studies on male SLE have suggested a higher 
mortality due to kidney and hematological disease and 
for male SLE patients to be more likely to be of African 
descent.16 In general, differences between males and 
females are numerous and more striking in Caucasians, 
especially with respect to lupus nephritis, abnormal 
serologies and thrombosis.15  
 
However, a full explanation for why the disease is so 
uncommon in men remains elusive and which patterns 
maybe representative for males with SLE. We sought to 
examine the clinical pattern in male SLE patients in the 
Ghana Lupus Cohort in order to improve the body of 




We retrospectively assessed the medical records of 13 
male patients diagnosed with Systemic Lupus 
erythematosus (SLE) who were attendant at the 
rheumatology clinic of Korle-Bu Teaching Hospital 
(KBTH), Male patients who were diagnosed to have SLE 
using clinical and laboratory criteria in keeping the 
American College of Rheumatology (ACR) criteria17 and 
followed up in our cohort, had their data collected 
retrospectively. There was a total of 134 SLE patients 
diagnosed between January 2014 and January 2017.  
 
Patients were only included if they had at least one 
follow-up visit. Patients with only discoid lupus were 
excluded. The patients had all been under the care of the 
Rheumatologists at the KBTH and were subject to usual 
care and or more frequent reviews as dictated by their 
condition. 
 
Information recorded at cohort entry (and updated at each 
visit) consists of basic demographic characteristics (date 
of birth, age at SLE onset, ethnicity, sex, socioeconomic 
status, and years of education, occupation, presenting and 
cumulative clinical manifestations. Laboratory tests 
included the complete blood cell count, erythrocyte 
sedimentation rate, serum creatinine, cholesterol, 
urinalysis, urine protein to creatinine ratio, C3, C4, and 
anti-dsDNA.  
 
These are done as requested per visit with some patients 
having limitation to do all tests due to financial 
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Collaborating Clinics/ACR Damage Index 18 is updated 
every 6 months. Treatment and the outcome of the 
condition were recorded. 
 
Data was collected by means of an anonymous and 
confidential data sheet from the patients’ files. The 
researchers first went through the patients’ files to ensure 
that the patients included in the study sample were known 
SLE patients and collected the required demographic and 
disease information. A pilot study was conducted on the 
files of first five male SLE patients.  
 
The data sheet was amended after the pilot study. 
Approval for the study was obtained from the Korle-Bu 
Teaching Hospital KBTH scientific and technical 
committee STC 00032/2018 for the study to be 
conducted. There was no need for informed consent as it 
was retrospective review of charts. 
 
Statistical analysis 
Data analysis was done using IBM SPSS Version 23. 
Continuous variables such as age, duration of illness and 
biochemical parameters were presented as means ± 
standard deviation. Categorical variables were presented 
as proportions. Statistical differences between the means 
and proportions were determined using the Student t-test, 
Chi square (x2) and Fisher’s exact test where appropriate. 
A p value ≤ 0.05 was considered statistically significant. 
 
RESULTS 
There were 134 patients in the entire KBTH Lupus 
Cohort at the time of analysis. A total of 13 male patients 
with SLE in the KBTH Lupus Cohort were included in 
our analysis. They were all black Africans, mean age 
30.62 ± SD8.47 yrs. with a range of 17 to 46 years. Most 
were Akans (50.0%) and had educational level up to 
tertiary level (75%) see Table 1.  
 
All of them (100%) presented with constitutional features 
including fever, weight loss and night sweats. 
Cumulative ACR criteria included 61.5 % rash, 54.5 % 
oral ulcers, 92.3% arthritis, 61.5 % serositis, 38.5% renal 
involvement, 46.2 % CNS involvement and 15.4 % 
hematological. 
 
Looking at their serological profile, 33.3 % had positive 
anti-dsDNA, 58.3 % Extractable nuclear antigens (ENA) 
mostly ribosomal antibodies in 58.3% and 91.7 % had a 
positive antinuclear antibody (ANA). See Table 2. 
 
Table 3 shows the medications the participants were 
receiving. The mean duration of illness from onset of 
symptoms to diagnosis was 21.31 months years (range 
one to 100 months).  
 
Male SLE patients had mean ESR value of 87.9 (p 
=0.001), CRP of 53.81(p= 0.041), Hemoglobin of 
9.21g/dl (p=0.001) and an average weight of 68.58 
(p=0.001). These data are presented in Table 4. 
 
Table 1 Demographic Characteristics of Male SLE 
Patients 
Demographic variables n (%) 
Ethnicity (N=12)  
Akan 6(50.0) 
Ga/Adamgbe 2(16.7) 
Ewe  3(25.0) 
Northern tribe 1(8.3) 
Place of birth (N=9)  
Northern Region 1(11.1) 
Eastern Region 1(11.1) 
Western Region 1(11.1) 
Central Region 1(11.1) 
Greater Accra Region 5(55.6) 
Marital Status (N=13)  
Single 7(53.8) 
Married 6(46.2) 




Occupation (N=12)  
Professional/Technical/Related 3 
Clerical work 1 









Cardiovascular System 4(30.8) 
Central Nervous System 6(46.2) 
Musculoskeletal System 12(92.3) 
Dermatological 8 (61.5) 
Gastrointestinal System 5(38.5) 
Respiratory System 8(61.5) 
Genito-urinary System 10(76.9) 
Infections (Past or Present) 1(7.7) 
Serology tests  
Antinuclear Antibodies 11(91.7) 
Anti-double Stranded DNA 4(33.3) 
Extractable Nuclear Antigens 7(58.3) 
Ab to ENA – Smith 4(33.3) 
Ab to ENA – Ro(SS-A) 4(33.3) 
Ab to ENA – La(SS-B) 3(25.0) 
Ab to ENA Ribosomal P 7(58.3) 




The average urine albumin creatinine ratio was 63.35 
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nephritis, all of them at time of diagnosis. There were no 
mortalities among the male SLE patients at the time of 
the study. 
 
Table 3 Medication use among male SLE patients 
Treatment n (%) 
Steroids (Oral/Injectable) 12(92.3) 
Hematinic 2(15.4) 
NSAIDs 6(46.2) 
Proton Pump Inhibitors 10(76.9) 
Azathioprine 3(23.1) 






dsDNA: Double stranded deoxyribonucleic acid Ab: Antibodies 
ENA: Extractable nuclear antigen, ESR: Erythrocyte sedimentation 
rate SLE: Systemic lupus erythematosus 
 
Table 4 Age and baseline laboratory variables of Male 
SLE patients in Ghana 




Age of patient (yrs.) 13 30.62 (8.47) 
Erythrocyte sedimentation rate 10 87.90 (41.24) 
C-Reactive Protein 10 53.81 (71.49) 
Hemoglobin level 11 9.21 (1.95) 
White Blood cell count 11 5.53 (2.68) 
Platelet Count 11 266.45 (42.30) 
URINEACR 7 63.35 (104.48) 
complementc3 10 88.85 (37.95) 
complementc4 10 21.93 (12.47) 
ACR: albumin creatinine ratio 
 
DISCUSSION 
SLE is uncommon in males compared to females, 
especially during the childbearing years. 2 Because of the 
notion that SLE patients tend to be women, there may be 
a tendency to think about SLE as a possible diagnosis late 
in male patients presenting with symptoms that may not 
be typical like a rash or arthralgia and this can lead to a 
delay in diagnosis in men especially those who present 
with atypical symptoms.2  
 
From this cohort, the ratio of male to female SLE cases 
was 1: 9.3. This compares with what Lu, Wallace et al. 
found which determined the incidence of SLE to  be 
markedly increased in females of child-bearing age with 
a ratio of 8-15:1.2 Font et al reported that out of the 261 
patients with SLE, 30 were men (11.5%; female/male 
ratio 8.7:1).19 This correlates with the findings of our 
study, where 10% were males. Similarly, Juan Liu et al 
also reported a female-to-male ratio of 8.14 to 1.20 The 
mean age of male SLE patients in this cohort was 30.62 
± 8.47 years with a range of 17 to 46 years. demonstrating   
a younger age at diagnosis compared to the mean age of 
disease onset of  34 years (range14- 64) reported  by Font 
et al 19.  
 
Other studies have also showed an older population of 
patients at diagnosis with a mean age of 37.94±16.96 
(range 10-87 years) and 35 ± 16.9years in another 
study.20, 21  
 
The mean age was however older in our study compared 
to that done by Garcia MA et al where their cohort of 
male SLE patients were much younger with a median age 
at disease onset of 27 years and that at diagnosis of 29.2 
years. (16) Males have been reported to experience their 
first SLE-related symptoms at a mean age range of 26 to 
38.4 years in comparison with females who range from 
26.3 to 31.9 years. The mean age range at diagnosis in 
males is reported to be between 26 to 55 years with 
females being diagnosed at a mean age of 27.9 to 42.6 
years.22, 23 Males therefore in other cohorts tend to be 
older both at diagnosis and at onset of disease symptoms. 
This may make diagnosis even more challenging as 
persons with SLE are typically assumed to be younger in 
the reproductive ages. 
 
 The mean duration of illness from onset of symptoms to 
diagnosis was 21.31 months, this is shorter compared to 
a study by Font et al where the mean duration of illness 
from onset of symptoms to diagnosis was 79 months.19  
Some studies report shorter duration of disease to 
diagnosis, but with evidence of disease causing damage 
to organs at the onset, which is reflected in  higher early 
damage scores, Higher damage scores are  associated 
with poor prognosis.20 This suggests there may be more 
aggressive disease if males causing damage early despite 
their early diagnosis or males may under report 
symptoms that would have made diagnosis earlier. 
 
Among African American population, median time from 
the first recorded criteria to diagnosis was significantly 
shorter in African-American (AA) males compared with 
AA females and also compared to European American 
(EA) females and males combined. African-American 
men progress from initial clinical manifestations to SLE 
diagnosis more rapidly than other ethnic or gender 
groups.24 This would reflect what happens in our cohort 
as well, with rapid symptoms making diagnosis faster 
and earlier damage due to more aggressive disease. 
 
Clinical features 
The main clinical presentation of SLE in men in our 
cohort was arthritis, rash, oral ulcers and serositis which 
occurred at a higher frequency.  
Constitutional symptoms of fever, weight loss and night 
sweats were elicited in all the patients. The most common 
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which 92.3% of our study population had. Our findings 
are comparable to a study done by Blažíčková and 
Rovenský where the most common symptom 
experienced was arthritis.21  
 
A significant number of males had major organ 
involvement namely renal and CNS, with 5 patients 
(38.46%) diagnosed with lupus nephritis at the time of 
diagnosis and % having CNS involvement. This is 
consistent with other studies which recorded higher 
incidence of end organ damage in males. Nephritis is a 
common feature in studies looking at male SLE 
patients.20, 25-28 Font et al found the incidence of 
nephropathy, neurological disease, thrombocytopenia, 
vasculitis, and serositis to be similar among males and 
females. 29 In study by Juan Liu et al 85.9% of males had 
renal involvement .20  
This is higher than the findings of our study whereby five 
patients (38.5%) were diagnosed with lupus nephritis. 
Male SLE is associated with higher incidence of 
nephropathy, cardiovascular involvement, thrombotic 
phenomena and anti-ds-DNA antibodies which confer a 
higher mortality rate.22  
 
Other studies report shorter delay to diagnosis, higher 
incidence of fever, weight loss, arterial hypertension, 
hemolytic anemia, IgG anticardiolipin antibodies and 
low complement among male SLE patients.29 Another 
study done amongst Indian men with SLE showed that 
males have an earlier age of disease onset, a higher 
incidence of mucocutaneous and renal involvement and 
a lower incidence of neuropsychiatric, gastrointestinal 
and hematological disease in comparison to those 
published from the developed countries. A higher 
frequency of infection, particularly tuberculosis was seen 
which the cause of some deaths was.30 Recent studies 
suggest organ impairment tend to occur in older men with 
SLE and they have higher mortality in one year 
suggesting men with lupus have a more complex clinical 
course.23, 31 What drives this would be a focus of further 
studies. 
  
Antibody profile and outcome 
Antinuclear antibodies (ANA) (90.9%) were the most 
common serological marker identified. Anti-dsDNA 
which is thought to confer a higher mortality rate was 
found in about a third (33.3%) of the patients. Juan Liu et 
al found in the Chinese population,  47.1% of male SLE  
patients had a  positive anti-dsDNA, and similar numbers 
as in our cohort ( 90.6%)  had positive antinuclear 
antibody which compares with the findings of this 
study.20 Most studies report a higher lupus anticoagulant 
positivity in male SLE patients20, this was however not 
checked in our cohort as a routine.  
Other studies have found no significant immunological 
differences between men and women.19 
 
Mortality also is reported to be higher in men,22, 25, 27 
however, none of our male SLE patients died in contrast  
to reports of higher mortality from most studies and 
despite the more aggressive disease. This observation 
would need further follow up to determine if this remains 
so as this is a young cohort with a short follow-up period. 
The diagnosis of SLE should  be considered in any 
patient with systemic symptoms including males, which 
would lead to less delay in diagnosis and management 
and help prevent irreversible damage to target organs.31 
 
CONCLUSION 
Male SLE patients in our inception cohort in Ghana show 
similar clinical features comparable to other populations, 
with arthritis and constitutional features as a predominant 
early feature, and Lupus nephritis being the main early 
indicator of damage. There were however no mortalities. 
This should warrant aggressive management in male 
patients as damage tends to occur early and there should 




1. Tiffin N, Adeyemo A and Okpechi I. A diverse array 
of genetic factors contribute to the pathogenesis of 
systemic lupus erythematosus. Orphanet journal of 
rare diseases. 2013; 8: 2. 
2. Lu LJ, Wallace DJ, Ishimori ML, Scofield RH and 
Weisman MH. Review: Male systemic lupus 
erythematosus: a review of sex disparities in this 
disease. Lupus. 2010; 19: 119-29. 
3. Tucker LB MS, Schaller JG, Isenberg DA. Adult and 
childhood onset systemic lupus erythematosus: a 
comparison of onset, clinical features, serology, and 
outcome. Br J Rheumatol. 1995: 866–72. 
4. Lisnevskaia L, Murphy G and Isenberg D. Systemic 
lupus erythematosus. The Lancet. 2014; 384: 1878-
88. 
5. Yacoub Wasef SZ. Gender differences in systemic 
lupus erythematosus. Gender medicine. 2004; 1: 12-
7. 
6. Inman RD, Jovanovic L, Markenson JA, Longcope 
C, Dawood MY and Lockshin MD. Systemic lupus 
erythematosus in men. Genetic and endocrine 
features. Archives of internal medicine. 1982; 142: 
1813-5. 
7. Renau AI and Isenberg DA. Male versus female 
lupus: a comparison of ethnicity, clinical features, 
serology and outcome over a 30 year period. Lupus. 




                                                                                              
www.ghanamedj.org  Volume 53 Number 1 March 2019 7 
8. Cattalini M, Soliani M, Caparello MC and Cimaz R. 
Sex Differences in Pediatric Rheumatology. Clinical 
reviews in allergy & immunology. 2017. 
9. Krasselt M and Baerwald C. Sex, Symptom 
Severity, and Quality of Life in Rheumatology. 
Clinical reviews in allergy & immunology. 2017. 
10. Costenbader KH FD, Stamper MJ, Karlson EW. 
Reproductive and menopausal factors and risk of 
systemic lupus erythematosus in women. Athritis 
Rheumatology. 2007; 56: 1251-62. 
11. Scofield RH, Bruner GR, Namjou B, et al. 
Klinefelter's syndrome (47,XXY) in male systemic 
lupus erythematosus patients: support for the notion 
of a gene-dose effect from the X chromosome. 
Arthritis and rheumatism. 2008; 58: 2511-7. 
12. Dillon S AR, Harding JW,et al. Klinefelter's 
syndrome (47,XXY) among men with systemic 
lupus erythematosus. Acta Paediatr. 2011; 100: 819-
23. 
13. Mok CC and Lau CS. Profile of sex hormones in 
male patients with systemic lupus erythematosus. 
Lupus. 2000; 9: 252-7. 
14. Murphy G and Isenberg D. Effect of gender on 
clinical presentation in systemic lupus 
erythematosus. Rheumatology. 2013; 52: 2108-15. 
15. Tan TC, Fang H, Magder LS and Petri MA. 
Differences between Male and Female Systemic 
Lupus Erythematosus in a Multiethnic Population. 
The Journal of rheumatology. 2012; 39: 759-69. 
16. Wallace DJ PT, Weiner J, James RK, Forouzesh S, 
Dubois E L:. Systemic lupus erythematosus – 
Survival patterns.Experience with 609 patients. 
JAMA. 1981: 934-8. 
17. Hochberg MC. Updating the American College of 
Rheumatology revised criteria for the classification 
of systemic lupus erythematosus. Arthritis and 
rheumatism. 1997; 40: 1725. 
18. Gladman DD, Goldsmith CH, Urowitz MB, et al. 
The Systemic Lupus International Collaborating 
Clinics/American College of Rheumatology 
(SLICC/ACR) Damage Index for Systemic Lupus 
Erythematosus International Comparison. The 
Journal of rheumatology. 2000; 27: 373-6. 
19. J Font RC, M Navarro, L Pallarés, A López-Soto, J 
Vivancos, and M Ingelmo. Systemic lupus 
erythematosus in men: clinical and immunological 
characteristics. Annals of the Rheumatic Diseases. 
1992; 51: 1050–2. 
20. Juan Liu FY, Dianjing Sui, Qiaoyan Guo, 
Changqing Dong, Jing Wang, Ping Nie, Liming 
Yang, Ping Luo. Clinical and pathological 
characteristics of male patients with systemic lupus 
erythematosus from northeast China: a ten-year 
retrospective study. Int J Clin Exp Pathol. 2017; 10: 
6082-91. 
21. Blažíčková S RJ. Systemic Lupus Erythematosus 
Detected in Males in the Population of Slovakia. J 
Nephrol urol. 2017; 1: 6. 
22. Garcia MA, Marcos JC, Marcos AI, et al. Male 
systemic lupus erythematosus in a Latin-American 
inception cohort of 1214 patients. Lupus. 2005; 14: 
938-46. 
23. Prete PE, Majlessi A, Gilman S and Hamideh F. 
Systemic lupus erythematosus in men: a 
retrospective analysis in a Veterans Administration 
Healthcare System population. Journal of clinical 
rheumatology : practical reports on rheumatic & 
musculoskeletal diseases. 2001; 7: 142-50. 
24. Arbuckle MR, McClain MT, Rubertone MV, et al. 
Development of autoantibodies before the clinical 
onset of systemic lupus erythematosus. The New 
England journal of medicine. 2003; 349: 1526-33. 
25. Molina JF, Drenkard C, Molina J, et al. Systemic 
lupus erythematosus in males. A study of 107 Latin 
American patients. Medicine (Baltimore). 1996; 75: 
124-30. 
26. Andrade RM, Alarcon GS, Fernandez M, Apte M, 
Vila LM and Reveille JD. Accelerated damage 
accrual among men with systemic lupus 
erythematosus: XLIV. Results from a multiethnic 
US cohort. Arthritis and rheumatism. 2007; 56: 622-
30. 
27. Kaufman LD, Gomez-Reino JJ, Heinicke MH and 
Gorevic PD. Male lupus: retrospective analysis of 
the clinical and laboratory features of 52 patients, 
with a review of the literature. Seminars in arthritis 
and rheumatism. 1989; 18: 189-97. 
28. Blum A, Rubinow A and Galun E. Predominance of 
renal involvement in male patients with systemic 
lupus erythematosus. Clinical and experimental 
rheumatology. 1991; 9: 206-7. 
29. Font J, Cervera R, Navarro M, et al. Systemic lupus 
erythematosus in men: clinical and immunological 
characteristics. Annals of the Rheumatic Diseases. 
1992; 51: 1050-2. 
30. Pande I, Malaviya AN, Sekharan NG, Kailash S, 
Uppal SS and Kumar A. SLE in Indian men: analysis 
of the clinical and laboratory features with a review 
of the literature. Lupus. 1994; 3: 181-6. 
31. do Socorro Teixeira Moreira Almeida M, da Costa 
Arcoverde J, Barros Jacobino MN and Coimbra 
Neto AR. Male systemic lupus erythematosus, an 
overlooked diagnosis. Clinics and Practice. 2011; 1: 
e103.
 
Copyright © The Author(s). This is an Open Access article under the CC BY license. 
 
